NDC 52959-910 - Hypertenipine
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 52959-910
- Package NDCs from labels
- 52959-910-30
- Manufacturer
- Physician Therapeutics LLC | InvaGen Pharmaceuticals, Inc | H.J. Harkins Company, Inc. | Targeted Medical Pharma, Inc.
- Effective date
- 2011-08-01
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Hypertenipine-2.5 | Physician Therapeutics LLC | InvaGen Pharmaceuticals, Inc | H.J. Harkins Company, Inc. | Targeted Medical Pharma, Inc. | 2011-08-01 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 52959-910-30 | Hypertenipine | 30 in 1 BOTTLE | TABLET | 30 | 2.5 mg | 7 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | Epic Pharma, LLC | 090f3e51-8129-4b5d-97f9-ab410e14df2d | 2025-12-17 | Warnings, Adverse reactions | 308136 864V2Q084H |
| Amlodipine Besylate and Benazepril Hydrochloride | AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE | A-S Medication Solutions | 7a75935a-31af-4571-b7d9-8c297a635b57 | 2025-12-16 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Exforge HCT | AMLODIPINE VALSARTAN AND HYDROCHLOROTHIAZIDE | Novartis Pharmaceuticals Corporation | 18d7820d-471f-4ee2-9ec6-25d8d27c77de | 2025-12-12 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Ascend Laboratories, LLC | 2b0bcb95-dc85-46f7-8b69-ca55cd58b30e | 2025-12-10 | Warnings, Adverse reactions | 308136 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | QPharma Inc | 3f74ed2b-4712-4026-ac2c-9239a211dde3 | 2025-12-05 | Warnings, Adverse reactions | 864V2Q084H |
| AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | Cipla USA Inc. | 5409b296-3bed-47cd-abba-9fe6f6833af6 | 2025-12-03 | Warnings, Adverse reactions | 308136 864V2Q084H |
| Amlodipine besylate and Olmesartan medoxomil | AMLODIPINE BESYLATE AND OLMESARTAN MEDOXOMIL | Ajanta Pharma USA Inc. | 69fa6293-b10a-4473-ab9b-1bd53f099bdd | 2025-11-30 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| OLMESARTAN MEDOXOMIL, AMLODIPINE and HYDROCHLOROTHIAZIDE | OLMESARTAN MEDOXOMIL, AMLODIPINE BESYLATE AND HYDROCHLOROTHIAZIDE | Micro Labs Limited | 9fb71df8-f70f-47dc-9465-8d8748261caf | 2025-11-29 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Vital Female Sexual Energy | AGNUS CASTUS, ARNICA MONTANA, AVENA SATIVA, CAULOPHYLLUM THALICTROIDES, CINCHONA OFFICINALIS, DAMIANA, HYPOPHYSIS SUIS, L-ARGININE, NATRUM MURIATICUM, ONOSMODIUM VIRGINIANUM, OOPHORINUM SUIS, PHOSPHORICUM ACIDUM, SEPIA, THUJA OCCIDENTALIS | Liddell Laboratories, Inc. | 1ca43c82-62b0-4191-81a4-27f7f94109dd | 2025-11-20 | Warnings | 94ZLA3W45F |
| Aminosyn II | ISOLEUCINE, LEUCINE, LYSINE ACETATE, METHIONINE, PHENYLALANINE, THREONINE, TRYPTOPHAN, VALINE, ALANINE, ARGININE, ASPARTIC ACID, GLUTAMIC ACID, HISTIDINE, PROLINE, SERINE, N-ACETYLTYROSINE, AND GLYCINE | ICU Medical Inc. | 5b426208-f090-4650-86c3-89040ba45c2d | 2025-11-02 | Boxed warning, Warnings, Adverse reactions | 94ZLA3W45F |
| Amlodipine and Atorvastatin | AMLODIPINE AND ATORVASTATIN | Bryant Ranch Prepack | be709711-e7ee-403f-ad43-873761deee37 | 2025-10-30 | Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate and Benazepril Hydrochloride | AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE | A-S Medication Solutions | 3ad66075-0875-4703-9d21-a424b5ab892a | 2025-10-29 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Boswell Pharmacy Services LLC d/b/a BPS Wholesale | 41af64c4-b788-d827-e063-6394a90a9157 | 2025-10-21 | Warnings, Adverse reactions | 864V2Q084H |
| Aminosyn-PF | ISOLEUCINE, LEUCINE, LYSINE ACETATE, METHIONINE, PHENYLALANINE, THREONINE, TRYPTOPHAN, VALINE, ALANINE, ARGININE, ASPARTIC ACID, GLUTAMIC ACID, GLYCINE, HISTIDINE, PROLINE, SERINE, TAURINE, AND TYROSINE | ICU Medical Inc. | 2d212e10-7e08-4aeb-b63f-dcc927897769 | 2025-10-17 | Warnings, Adverse reactions | 94ZLA3W45F |
| Amlodipine Besylate and Benazepril Hydrochloride | AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE | A-S Medication Solutions | c9693ad5-0fa6-4796-b20b-2021d589a132 | 2025-10-15 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | PD-Rx Pharmaceuticals, Inc. | 47114f60-4151-43d4-ac2d-adc49492a679 | 2025-10-15 | Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | PD-Rx Pharmaceuticals, Inc. | ac0dd8fb-ebe1-4d02-bd0d-4f979c6e3608 | 2025-10-15 | Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine and Benazepril Hydrochloride | AMLODIPINE AND BENAZEPRIL HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 02e233c4-48d1-456d-8fc8-f99a06ef854a | 2025-10-14 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | Quallent Pharmaceuticals Health LLC | c262dedb-1d13-4447-9355-f11e1dbbfb4d | 2025-10-13 | Warnings, Adverse reactions | 308136 864V2Q084H |
| Aminosyn-PF | ISOLEUCINE, LEUCINE, LYSINE ACETATE, METHIONINE, PHENYLALANINE, THREONINE, TRYPTOPHAN, VALINE, ALANINE, ARGININE, ASPARTIC ACID, GLUTAMIC ACID, GLYCINE, HISTIDINE, PROLINE, SERINE, TAURINE, AND TYROSINE | ICU Medical Inc. | 46e74ce4-cd7e-437f-bf54-ca9b98eb2663 | 2025-10-10 | Boxed warning, Warnings, Adverse reactions | 94ZLA3W45F |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.